Skip to main content
. 2022 Apr 13;9(2):ENEURO.0522-21.2022. doi: 10.1523/ENEURO.0522-21.2022

Table 2.

General electrophysiological parameters from recordings 1 and 3 d after administration of PEGPH20 or vehicle

Condition
Vehicle 1 d Vehicle 3 d
Conduction 10.56 ± 1.99 6.71 ± 1.37
velocity (n = 27) (n = 21)
Mechanical threshold 2.77 ± 1.08 4.29 ± 1.52
(n = 9) (n = 7)
Mechanical response 44.02 ± 18.57 108.80 ± 50.19
(peak IF, Hz) (n = 9) (n = 7)
Heat response 3.03 ± 0.95 4.7 ± 0.0
(peak IF, Hz) (n = 2) (n = 1)
Cold response 63.53 ± 18.53 34.90 ± 33.20
(peak IF, Hz) (n = 2) (n = 2)
Low metabolite response 13.4 ± 0.0 26.58 ± 23.24
(peak IF, Hz) (n = 1) (n = 4)
Hight metabolite response 1.39 ± 0.64 8.37 ± 6.19
(peak IF, Hz) (n = 3) (n = 4)
  Condition
  PEGPH20 1d PEGPH20 3d
Conduction 6.487 ± 1.18 10.33 ± 1.92
velocity (n = 24) (n = 24)
Mechanical threshold 5.2 ± 1.11 1.92 ± 1.17
(n = 9) (n = 7)
Mechanical response 77.41 ± 9.95 88.07 ± 31.53
(peak IF, Hz) (n = 9) (n = 7)
Heat response 26.7 ± 0.0 7.9 ± 1.5
(peak IF, Hz) (n = 1) (n = 2)
Cold response No cold responses
recorded
39.48 ± 18.73
(peak IF, Hz) (n = 4)
Low metabolite response 3.9 ± 1.45 30.66 ± 12.09
(peak IF, Hz) (n = 5) (n = 7)
Hight metabolite response 13.16 ± 4.62 37.82 ± 14.05
(peak IF, Hz) (n = 4) (n = 5)

We do not observe any significant differences between electrophysiological recordings performed either 1 or 3 d after treatment in each condition.